Angel Biotechnology consolidating business after asset boosting year – Proactive Investors UK
By Dr. Matthew Watson
 Proactive Investors UK | Angel Biotechnology consolidating business after asset boosting year Proactive Investors UK Angel Biotechnology (LON:ANH) said it will concentrate on consolidating the business after an 'intense' asset boosting period of change. Angel, which manufactures products for drug development firms, increased its total assets to £2.7 million in the ... Move puts biotech firm into the rednebusiness.co.uk New site costs hit Angel's revenueHerald Scotland |
Source:
http://news.google.com/news?q=biotechnology&output=rss
Uncategorized
Comments Off on Angel Biotechnology consolidating business after asset boosting year – Proactive Investors UK |
June 3rd, 2012
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research